Immune responses during human schistosomiasis mansoni. XV. Anti-idiotypic T cells can recognize and respond to anti-SEA idiotypes directly.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 3127466)

Published in J Immunol on April 01, 1988

Authors

J C Parra1, M S Lima, G Gazzinelli, D G Colley

Author Affiliations

1: Departmento de Bioquimica e Imunologia, Universidade Federal de Minas Gerais, Brazil.

Articles by these authors

C3 shunt activation in human serum chelated with EGTA. J Immunol (1972) 6.94

Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol (1993) 2.92

Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in vitro. Exp Parasitol (1974) 2.54

Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Infect Immun (1975) 2.04

Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol (1973) 1.89

Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg (1993) 1.87

Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg (1997) 1.83

Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev (2003) 1.83

Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun (2003) 1.81

Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg (1993) 1.73

Immune responses to a soluble schistosomal egg antigen preparation during chronic primary infection with Schistosoma mansoni. J Immunol (1975) 1.72

Cellular differentiation in the thymus. 3. Surface properties of rat thymus and lymph node cells separated on density gradients. J Exp Med (1970) 1.60

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev (2007) 1.59

Immunologic aspects of host responses to schistosomiasis: resistance, immunopathology, and eosinophil involvement. Prog Allergy (1978) 1.39

Schistosomiasis vaccine:research to development. Parasitol Today (1998) 1.38

Adoptive suppression of granuloma formation. J Exp Med (1976) 1.38

Schistosomal egg antigen-induced lymphocyte blastogenesis in experimental murine Schistosoma mansoni infection. J Immunol (1971) 1.33

Large-scale laboratory maintenance of Schistosoma mansoni, with observations on three schistosome/snail host combinations. J Parasitol (1986) 1.33

Schistosoma mansoni: simplified method for the production of schistosomules. Exp Parasitol (1974) 1.30

Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells. J Immunol (1979) 1.30

Immune responses during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocyte blastogenic responses to schistosome antigen preparations. Am J Trop Med Hyg (1977) 1.29

In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-gamma mRNA, and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spleens during the course of modulation. J Immunol (1992) 1.28

Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int Arch Allergy Appl Immunol (1977) 1.28

Prevalence of trachoma in school children and ophthalmological outpatients in rural Egypt. Am J Trop Med Hyg (1987) 1.27

Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection. Proc Natl Acad Sci U S A (1981) 1.27

The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals. AIDS (2000) 1.26

Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis (2001) 1.24

In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance. J Immunol (1988) 1.23

Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide. Cell Immunol (1979) 1.23

Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg (1998) 1.20

Eosinophils and immune mechanisms: production of the lymphokine eosinophil stimulation promoter (ESP) in vitro by isolated intact granulomas. J Reticuloendothel Soc (1975) 1.19

Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today (2000) 1.17

Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp Parasitol (1972) 1.17

Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol (1994) 1.16

Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A. J Immunol (1978) 1.15

Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am J Pathol (1973) 1.14

Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol (1996) 1.14

Intradermal immune responses to a schistosomal egg antigen during experimental murine Schistosoma mansoni infection. Proc Soc Exp Biol Med (1972) 1.14

IFN-gamma in human Chagas' disease: protection or pathology? Braz J Med Biol Res (1998) 1.13

Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. II. Pathology and altered pathogenesis. Am J Pathol (1973) 1.13

Mixed lymphocyte blastogenesis in response to multiple histocompatibility antigens. J Immunol (1969) 1.12

Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J Infect Dis (2000) 1.12

Active anaphylactic reaction in mouse peritoneal mast cells in vitro. Life Sci (1966) 1.12

Immune responses during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis. J Immunol (1983) 1.11

Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am J Trop Med Hyg (2000) 1.11

T lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. J Immunol (1981) 1.08

The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans R Soc Trop Med Hyg (1990) 1.06

Cytokine regulation of human immune response to Schistosoma mansoni: analysis of the role of IL-4, IL-5 and IL-10 on peripheral blood mononuclear cell responses. Scand J Immunol (1997) 1.06

Factors affecting high and low human IgE responses to schistosome worm antigens in an area of Brazil endemic for Schistosoma mansoni and hookworm. Am J Trop Med Hyg (1997) 1.05

Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect Immun (2006) 1.05

Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz J Med Biol Res (1998) 1.05

Cytotoxic effect of normal rabbit serum on rat lymphoid cells. Transplantation (1970) 1.04

Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg (1995) 1.04

Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol (1997) 1.04

Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am J Trop Med Hyg (1993) 1.03

Effect of the venom of the scorpion Tityus serrulatus on adrenal gland catecholamines. Toxicon (1968) 1.03

Immune responses during human Schistosomiasis mansoni. VIII. Differential in vitro cellular responsiveness to adult worm and schistosomular tegumental preparations. Am J Trop Med Hyg (1983) 1.02

Idiotype stimulation of T lymphocytes from Trypanosoma cruzi-infected patients. J Immunol (1988) 1.02

Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease. Am J Trop Med Hyg (1986) 1.02

Immunosuppression mediated by adult worms in chronic schistosomiasis mansoni. Am J Trop Med Hyg (1977) 1.01

Eosinophil-mediated destruction of Schistosoma mansoni eggs III. lymphokine involvement in the induction of eosinophil functional abilities. Cell Immunol (1978) 1.01

Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations. J Immunol (1979) 1.00

Passive anaphylactic reaction in mouse peritoneal mast cells in vitro. Life Sci (1966) 1.00

Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunol (1991) 1.00

Partial purification and characterization of Schistosoma mansoni soluble egg antigen with Con A-Sepharose chromatography. J Immunol (1979) 1.00

Immunoaffinity purification of Schistosoma mansoni soluble egg antigens. J Immunol (1979) 0.98

Human antibody responses against schistosomal antigens. I. Antibodies from patients with Ancylostoma, Ascaris lumbricoides or Schistosoma mansoni infections react with schistosome antigens. Am J Trop Med Hyg (1988) 0.98

Immune responses during human schistosomiasis mansoni. XVIII. Immunologic status of pregnant women and their neonates. Scand J Immunol (1992) 0.98

The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz (1999) 0.98

Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area. Parasite Immunol (1995) 0.98

Idiotypic sensitization in utero of children born to mothers with schistosomiasis or Chagas' disease. J Clin Invest (1989) 0.97

Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol (1998) 0.97

Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol (2000) 0.97

Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection. Exp Parasitol (1996) 0.96

Eosinophils and immune mechanisms. VI. The synergistic combination of granulocyte-macrophage colony-stimulating factor and IL-5 accounts for eosinophil-stimulation promoter activity in Schistosoma mansoni-infected mice. J Immunol (1990) 0.96

Eosinophil-mediated destruction of Schistosoma mansoni eggs. J Reticuloendothel Soc (1976) 0.96

Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses. Infect Immun (1990) 0.95

In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. I. IL-4 mRNA, not IL-2 mRNA, is abundant in the granulomatous livers, mesenteric lymph nodes, and spleens of infected mice. J Immunol (1991) 0.95

Spleen cells from Schistosoma mansoni-infected mice produce diffusible stimulator of eosinophilopoiesis in vivo. Nature (1976) 0.95

Cellular differentiation in the thymus. II. Thymus-specific antigens in rat thymus and peripheral lymphoid cells. J Immunol (1970) 0.94

Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment. Trans R Soc Trop Med Hyg (1986) 0.94

Cellular immune responses of chagasic patients to antigens derived from different Trypanosoma cruzi strains and clones. Am J Trop Med Hyg (1986) 0.93

Antidepressants for anorexia nervosa. Cochrane Database Syst Rev (2006) 0.93

Eosinophils and immune mechanisms. IV. Culture conditions, antigen requirements, production kinetics and immunologic specificity of the lymphokine eosinophil stimulation promoter. Cell Immunol (1976) 0.93

Neonatal exposure to idiotype induces Schistosoma mansoni egg antigen-specific cellular and humoral immune responses. J Immunol (1999) 0.92